President Donald Trump's second term has proven tumultuous, but his troubles may have only just begun, according to one conservative commentator.In a Wednesday President Donald Trump's second term has proven tumultuous, but his troubles may have only just begun, according to one conservative commentator.In a Wednesday

Trump's 'tin-pot dictator' move guarantees his impeachment: conservative

2026/02/12 06:27
Okuma süresi: 3 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.

President Donald Trump's second term has proven tumultuous, but his troubles may have only just begun, according to one conservative commentator.

In a Wednesday essay for the conservative National Review, former federal prosecutor Andrew C. McCarthy – who was an assistant U.S. attorney under Presidents Bill Clinton and George W. Bush – lamented that Trump's Department of Justice (DOJ) was staking its credibility on pursuing weak investigations against the president's political opponents. McCarthy argued that the Trump DOJ's recent failure to indict six Democratic members of Congress over a video message will likely lead to Trump's eventual third impeachment should Democrats retake at least one chamber of Congress in this fall's midterm elections.

The National Review columnist argued that while he personally viewed the video (which encouraged active-duty troops to remember their duty to disobey illegal orders) as "craven but legally unimpeachable," Trump's crusade nonetheless constituted an act of "bullying."

"More even than capricious tariffs, the president’s signature policy is bullying lawfare — the tin-pot dictator-style exploitation of law-enforcement power to punish political enemies and scapegoats and to settle old scores," he wrote. "And no, the fact that lawfare was practiced against him does not excuse it since lawfare threatens our justice system’s legitimacy, which is vital to a flourishing, free republic."

McCarthy went on to assert "there was no plausible justification for the proposed indictment," citing the 1969 Brandenburg v. Ohio decision that guarantees expressions of speech will not be punished provide they don't incite acts of lawlessness. He noted that this was the same case that led to former President Joe Biden's DOJ to not prosecute Trump for his January 6, 2021 speech at the Ellipse in Washington D.C. that preceded the siege of the U.S. Capitol.

"The president’s disregard for settled constitutional principle is exacerbated by his affront to separation of powers. A president has no business indicting, threatening to indict, or attempting to indict members of Congress who have committed no crimes — over a policy dispute," he wrote. "As congressional Republicans must know — if they have any memory of their prior pose as guardians of our constitutional framework and of the Article I branch’s institutional prerogatives — it is the end of liberty if the executive can paralyze Congress by threatening it with prosecution."

According to McCarthy, the die has been cast, and Trump's failed attempt to indict the six Democrats in the video means an unprecedented third impeachment is all but assured.

"Democrats will respond to the president’s attack on them by impeaching him," he wrote. "The progressive base will accept nothing less, and at this point congressional Democrats will not need convincing."

  • george conway
  • noam chomsky
  • civil war
  • Kayleigh mcenany
  • Melania trump
  • drudge report
  • paul krugman
  • Lindsey graham
  • Lincoln project
  • al franken bill maher
  • People of praise
  • Ivanka trump
  • eric trump
Piyasa Fırsatı
OFFICIAL TRUMP Logosu
OFFICIAL TRUMP Fiyatı(TRUMP)
$3.085
$3.085$3.085
-1.43%
USD
OFFICIAL TRUMP (TRUMP) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Paylaş
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Paylaş
BitcoinEthereumNews2026/03/07 16:09